<?xml version="1.0" encoding="UTF-8"?>
<p>MBCs make up the second line of antibody-mediated defense, providing protection by rapidly activating, proliferating and secreting antibodies in response to cognate antigen. Once regarded as a backup to LLPC-derived antibodies, the specificity and breadth of potential MBC responses are increasingly appreciated, especially with regard to protection against heterogeneous but antigenically related viral pathogens, such as influenza, different serotypes of DENV, and viral escape mutants (
 <xref rid="B5" ref-type="bibr">5</xref>, 
 <xref rid="B7" ref-type="bibr">7</xref>).
</p>
